Novo Nordisk
NVO
#61
Rank
C$346.55 B
Marketcap
C$67.52
Share price
4.49%
Change (1 day)
-42.95%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): C$28.74 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are C$47.70 Billion. , an increase over its 2024 earnings that were of C$25.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 C$28.01 B9.13%
2024 C$25.67 B22.84%
2023 C$20.89 B57.81%
2022 C$13.24 B5.24%
2021 C$12.58 B12.38%
2020 C$11.19 B13.11%
2019 C$9.89 B-3.45%
2018 C$10.25 B1.88%
2017 C$10.06 B4.3%
2016 C$9.64 B10.32%
2015 C$8.74 B7.47%
2014 C$8.13 B3.4%
2013 C$7.87 B19.09%
2012 C$6.60 B15.58%
2011 C$5.71 B16.58%
2010 C$4.90 B25.66%
2009 C$3.90 B10.68%
2008 C$3.52 B55.82%
2007 C$2.26 B7.02%
2006 C$2.11 B19.05%
2005 C$1.77 B10.55%
2004 C$1.60 B
2002 C$1.12 B-14.39%
2001 C$1.31 B-52.82%
2000 C$2.78 B250%
1999 C$0.79 B31.21%
1998 C$0.60 B34.31%
1997 C$0.45 B11.46%
1996 C$0.40 B9.03%
1995 C$0.37 B-3.15%
1994 C$0.38 B-0.67%
1993 C$0.38 B45.38%
1992 C$0.26 B-13.81%
1991 C$0.30 B37.12%
1990 C$0.22 B-0.79%
1989 C$0.22 B26.2%
1988 C$0.17 B24.97%
1987 C$0.14 B-0.9%
1986 C$0.14 B-7.78%
1985 C$0.15 B24.87%
1984 C$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.07 B-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.52 B 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.34 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$10.89 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA